Rates of treated and untreated kidney failure in older vs younger adults

JAMA

Volumn 307, Issue 23, 2012, Pages 2507-2515

  Hemmelgarn, Brenda R ^a,b   James, Matthew T ^a,b   Manns, Braden J ^a,b   O'Hare, Ann M ^c   Muntner, Paul ^d   Ravani, Pietro ^a,b   Quinn, Robert R ^a,b   Turin, Tanvir Chowdhury ^a   Tan, Zhi ^a   Tonelli, Marcello ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL DECISION MAKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 84862502015     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.6455     Document Type: Article

References (32)

1. United States Renal Data System. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: United States Renal Data System Coordinating Center; 2003.
2. Jassal SV, Trpeski L, Zhu N, Fenton S, Hemmelgarn B. Changes in survival among elderly patients initiating dialysis from 1990 to 1999. CMAJ. 2007;177(9):1033-1038. (Pubitemid 350058089)
3. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007;146(3):177-183. (Pubitemid 351650630)
4. Hall YN, Choi AI, Chertow GM, Bindman AB. Chronic kidney disease in the urban poor. Clin J Am Soc Nephrol. 2010;5(5):828-835.
5. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659-663. (Pubitemid 38392981)
6. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758-2765. (Pubitemid 47531203)
7. Roderick PJ, Atkins RJ, Smeeth L, et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis. 2009;53(6):950-960.
8. Raymond NT, Zehnder D, Smith SC, Stinson JA, Lehnert H, Higgins RM. Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant. 2007;22(11):3214-3220. (Pubitemid 350202561)
9. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol. 2006;17(3):846-853.
10. Hemmelgarn BR, Clement F, Manns BJ, et al. Overview of the Alberta Kidney Disease Network. BMC Nephrol. 2009;10:30.
11. Levey AS, Stevens LA, Schmid CH, et al Chronic Kidney Disease Epidemiology Collaboration. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
12. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009;46(pt 3):205-217.
13. Bello A, Thompson S, Lloyd A, et al Alberta Kidney Disease Network. Multiple vs single and other estimates of baseline proteinuria status as predictors of adverse outcomes in the general population. AmJ Kidney Dis. 2012;59(3):364-371.
14. Clement FM, James MT, Chin R, et al Alberta Kidney Disease Network. Validation of a case definition to define chronic dialysis using outpatient administrative data. BMC Med Res Methodol. 2011;11:25.
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.AmJ Kidney Dis. 2002;39(2)(suppl 1):S1-S266.
16. Statistics Canada. Ethnocultural portrait of Canada highlight tables, 2006 Census. http://www12.statcan.ca/english/census06/data/highlights/ethnic/ index.cfm?Lang=E. Accessed September 15, 2011.
17. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25(3):512-516. (Pubitemid 41103345)
18. Quan H, Khan N, Hemmelgarn BR, et al Hypertension Outcome and Surveillance Team of the Canadian Hypertension Education Programs. Validation of a case definition to define hypertension using administrative data. Hypertension. 2009;54(6):1423-1428.
19. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. (Pubitemid 41587600)
20. Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118(3):392-404.
21. Fine JPG. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
22. Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. Am J Kidney Dis. 1998;31(3):464-472. (Pubitemid 28124100)
23. O'Hare AM, Rodriguez RA, Hailpern SM, Larson EB, Kurella TamuraM. Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA. 2010;304(2):180-186.
24. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007;10(6):1266-1276. (Pubitemid 350308628)
25. Murphy EL, Murtagh FE, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):c74-c80.
26. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802.
27. Dor A, Pauly MV, Eichleay MA, Held PJ. Endstage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ. 2007;7(2-3):73-111.
28. Rosansky S, Glassock RJ, Clark WF. Early start of dialysis: a critical review. Clin J AmSoc Nephrol. 2011;6(5):1222-1228.
29. Clark WF, Na Y, Rosansky SJ, et al. Association between estimated glomerular filtration rate at initiation of dialysis and mortality. CMAJ. 2011;183(1):47-53.
30. Matsushita K, van der Velde M, Astor BC, et al Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-2081.
31. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010;55(4):648-659.
32. Cooper BA, Branley P, Bulfone L, et al IDEAL Study. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609-619.